| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
2,476,000 | 2,480,000 | 2,229,000 | 2,683,000 | 2,765,000 |
Cost of Goods Sold (COGS) incl. D&A |
1,515,000 | 1,517,000 | 1,395,000 | 1,336,000 | 1,429,000 |
COGS excluding D&A |
1,220,000 | 1,245,000 | 1,147,000 | 1,105,000 | 1,169,000 |
Depreciation & Amortization Expense |
295,000 | 272,000 | 248,000 | 231,000 | 260,000 |
Gross Income |
961,000 | 963,000 | 834,000 | 1,347,000 | 1,336,000 |
SG&A Expense |
156,000 | 147,000 | 168,000 | 156,000 | 179,000 |
Research & Development |
90,000 | 74,000 | 82,000 | 102,000 | 126,000 |
Other SG&A |
66,000 | 73,000 | 86,000 | 54,000 | 53,000 |
Other Operating Expense |
78,000 | 123,000 | 98,000 | 136,000 | -71,000 |
Unusual Expense |
31,000 | -32,000 | -16,000 | 24,000 | 2,094,000 |
Non Operating Income/Expense |
162,000 | 57,000 | 42,000 | 52,000 | -129,000 |
Equity in Affiliates (Pretax) |
NA | 0 | 0 | 0 | 0 |
Interest Expense |
57,000 | 67,000 | 71,000 | 52,000 | 51,000 |
Gross Interest Expense |
87,000 | 67,000 | 71,000 | 52,000 | 51,000 |
Pretax Income |
804,000 | 717,000 | 557,000 | 1,036,000 | -1,046,000 |
Income Tax |
123,000 | 228,000 | 175,000 | 343,000 | -150,000 |
Equity in Affiliates |
-12,000 | -9,000 | -11,000 | -19,000 | -1,000 |
Consolidated Net Income |
669,000 | 480,000 | 371,000 | 674,000 | -897,000 |
Minority Interest Expense |
24,000 | 80,000 | 92,000 | 113,000 | 131,000 |
Net Income |
645,000 | 400,000 | 279,000 | 561,000 | -1,028,000 |
Extraordinaries & Discontinued Operations |
28,000 | -33,000 | 0 | -71,000 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
28,000 | -33,000 | 0 | -71,000 | 0 |
Net Income After Extraordinaries |
617,000 | 433,000 | 279,000 | 632,000 | -1,028,000 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
645,000 | 400,000 | 279,000 | 561,000 | -1,028,000 |
Operational EPS |
1.34 | 0.76 | 0.54 | 1.15 | 0.87 |
EPS (basic) |
1.36 | 0.74 | 0.56 | 0.99 | -2.08 |
EBITDA |
1,022,000 | 965,000 | 816,000 | 1,286,000 | 1,488,000 |
Depreciation & Amortization Expense |
295,000 | 272,000 | 248,000 | 231,000 | 260,000 |
Common Shares Outstanding |
497,000 | 496,000 | 496,000 | 495,000 | 504,000 |
Basic Shares Outstanding |
497,000 | 496,000 | 496,000 | 495,000 | 494,000 |
Diluted Shares Outstanding |
499,000 | 499,000 | 498,000 | 504,000 | 504,000 |
Diluted EPS after Extraordinary Items |
1.35 | 0.74 | 0.56 | 0.97 | -2.04 |
Discont. Operations Per Share |
0.06 | -0.07 | 0 | -0.14 | 0 |
Continued operations EPS |
1.30 | 0.81 | 0.56 | 1.13 | -2.04 |
*Figures in thousands of U.S. Dollars except shares outstanding.
